↓ Skip to main content

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma

Overview of attention for article published in PharmacoEconomics, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
4 policy sources

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
65 Mendeley
Title
Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma
Published in
PharmacoEconomics, October 2012
DOI 10.2165/00019053-200624070-00008
Pubmed ID
Authors

Gunnar Johansson, Emma B. Andreasson, Per E. Larsson, Claus F. Vogelmeier

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
United States 1 2%
Germany 1 2%
Unknown 62 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 20%
Other 10 15%
Researcher 10 15%
Student > Master 8 12%
Professor 4 6%
Other 11 17%
Unknown 9 14%
Readers by discipline Count As %
Medicine and Dentistry 30 46%
Pharmacology, Toxicology and Pharmaceutical Science 10 15%
Economics, Econometrics and Finance 4 6%
Nursing and Health Professions 3 5%
Agricultural and Biological Sciences 3 5%
Other 6 9%
Unknown 9 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2020.
All research outputs
#2,863,855
of 25,374,647 outputs
Outputs from PharmacoEconomics
#247
of 1,992 outputs
Outputs of similar age
#20,313
of 191,594 outputs
Outputs of similar age from PharmacoEconomics
#35
of 651 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,594 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 651 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.